Intermountain Medical Center participated in a trial of the first bioengineered external liver, designed to help acute liver failure patients or are not eligible for or are waiting for a transplant a ...

BRISBANE, Calif. and EDEN PRAIRIE, Minn., April 05, 2023 (GLOBE NEWSWIRE) -- CareDx, Inc. (CDNA) and Miromatrix Medical Inc. (MIRO) -- today announced an exclusive partnership aimed at advancing the ...

SAN DIEGO--(BUSINESS WIRE)-- Trestle Biotherapeutics, Inc., today announced a research collaboration with Humacyte, Inc. (HUMA) (Nasdaq: HUMA), a commercial-stage biotechnology platform company ...

A phase 1 study of miroliverELAP for the treatment of acute liver failure is currently underway;1 first patient in the study underwent the procedure at Intermountain Medical Center in Murray, Utah ...

Data is from comprehensive review of hospital charges and all-payer claims over five years - - Preventable complications such as amputation and conduit infection increased initial hospital charges by ...

Medera’s Novoheart partners with National Heart Centre Singapore (NHCS) to create the world’s first Asian patient-specific miniature human heart model with heart failure, known as “Human ...

An international team of researchers bioengineering human liver tissues uncovered previously unknown networks of genetic-molecular crosstalk that control the organ's developmental processes – greatly ...

Scientists at the University of Glasgow developed a bioengineered bone marrow (BM) model that helped them to evaluate potential use of a combined CRISPR-CAR T cell therapy in the treatment of acute ...

A new method to keep human lymph node tissue alive and functioning outside the body for several days could give researchers a much clearer view of how our immune system responds to infections, ...

- Patients treated with Symvess were observed to have high levels of patency, 100% limb salvage, and zero cases of conduit infection - "Vascular complications of medical or surgical procedures aren't ...